Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis

Life Sci. 2023 Jun 15:323:121662. doi: 10.1016/j.lfs.2023.121662. Epub 2023 Apr 5.

Abstract

The signalling system known as mammalian target of rapamycin (mTOR) is believed to be required for several biological activities involving cell proliferation. The serine-threonine kinase identified as mTOR recognises PI3K-AKT stress signals. It is well established in the scientific literature that the deregulation of the mTOR pathway plays a crucial role in cancer growth and advancement. This review focuses on the normal functions of mTOR as well as its abnormal roles in cancer development.

Keywords: Apoptosis; Pathological angiogenesis; Rapamycin and rapalogues; Signalling cascade; mTOR.

Publication types

  • Review

MeSH terms

  • Carcinogenesis
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Humans
  • Neoplasms* / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Sirolimus*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Sirolimus
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • MTOR protein, human